Home › Funds › Citadel Advisors › PRLD

Citadel Advisors position in PRLD

PRELUDE THERAPEUTICS INC · Health Care

Latest position (Q2 2026)16.10K sh
Reported value held$85.81K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 14.49K $453.00K New
Q4 2021 138.50K $1.73M Add
Q1 2022 222.30K $1.53M Add
Q2 2022 406.82K $2.12M Add
Q3 2022 160.93K $1.06M Reduce
Q4 2022 18.33K $110.72K Reduce
Q2 2023 38.57K $173.56K New
Q3 2023 301.50K $931.64K Add
Q4 2023 97.03K $414.32K Reduce
Q1 2024 30.00K $142.18K Reduce
Q2 2024 31.89K $121.49K Add
Q3 2024 16.02K $33.17K Reduce
Q4 2024 16.70K $21.29K Add
Q1 2025 23.93K $18.38K Add
Q1 2025 23.93K $18.38K Add
Q2 2025 33.62K $27.22K Add
Q2 2025 33.62K $27.22K Add
Q1 2026 124.38K $425.37K New
Q2 2026 16.10K $85.81K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding PRLD

All PRLD fund holders →